Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy (FAP): Updated Safety and Efficacy Najat Khan, Ph.D ., Chief R&D and Chief Commercial Officer and incoming CEO and ...

Two important architectures are Artificial Neural Networks and Long Short-Term Memory networks. LSTM networks are especially useful for financial applications because they are designed to work with ...

Instead of a single, massive LLM, Nvidia's new 'orchestration' paradigm uses a small model to intelligently delegate tasks to ...

Telling ChatGPT to fact-check a random answer before solving an actual problem makes it think harder, and get the answer right more often – even if the earlier 'random' answer has nothing to do with ...

Famed GTA developer Dan Houser said models trained on synthetic data could degrade game quality as creators rapidly adopt AI ...

Artificial intelligence and machine learning are reshaping how investors build and maintain portfolios. These tools bring ...

Environmental Engel curves characterize the relationship between the embodied environmental impact of household consumption ...

Artificial intelligence can already beat grandmasters at Go, draft legal briefs, and generate photorealistic images in ...

Paste Magazine is your source for the best music, movies, TV, comedy, videogames, books, comics, craft beer, politics and ...

Destiny 2's Renegades update is live this December 2 as console version 1.177/3.82. This ushers in the new Star Wars content ...

Factorial of 100 - The Factorial of Hundred (100!) is one of the most intriguing concepts in mathematics, representing the ...